Teladoc is facing pressure from an activist investor urging sweeping changes to cut costs and potentially break up the telemedicine giant to boost shareholder value.
What happened: In an open letter to the board, Pineal Capital Management said TDOC should allow for a share repurchase program of at least $200 million, saying the telemedicine company's balance sheet is "under-levered."
